• Fri, May 10, 2024
Serge Belanger Maintained (XENE) at Strong Buy and Held Target at $62 on, May 10th, 2024
Serge Belanger of Needham, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy and Held Target at $62 on, May 10th, 2024.
Serge has made no other calls on XENE in the last 4 months.
There are 2 other peers that have a rating on XENE. Out of the 2 peers that are also analyzing XENE, 0 agree with Serge's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Serge
- Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Wednesday, April 10th, 2024
- Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $55 on, Friday, March 1st, 2024
Like: 👍
